(“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing ...
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. MALMÖ, SE / ACCESS Newswire / January ...
Pharmaceuticals announced a streamlined strategic focus on advancing and realizing the potential of apraglutide for the ...
Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.
Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus ...
Clinical trial agreements (CTAs) form the foundation of any clinical research initiative, establishing the legal and ...
Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...
Individual funding requests policy Standard operating procedures for the management of individual funding requests Appendix four: IFR reconsideration form Appendix eight ... supported by a range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback